ID: ALA350508

Max Phase: Preclinical

Molecular Formula: C10H15N5O3

Molecular Weight: 253.26

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCC(CO)OCn1cnc2c(O)nc(N)nc21

Standard InChI:  InChI=1S/C10H15N5O3/c1-2-6(3-16)18-5-15-4-12-7-8(15)13-10(11)14-9(7)17/h4,6,16H,2-3,5H2,1H3,(H3,11,13,14,17)

Standard InChI Key:  HNZUVOSJSMIACT-UHFFFAOYSA-N

Associated Targets(Human)

ATH-8 cell line 300 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 253.26Molecular Weight (Monoisotopic): 253.1175AlogP: -0.14#Rotatable Bonds: 5
Polar Surface Area: 119.31Molecular Species: NEUTRALHBA: 8HBD: 3
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.58CX Basic pKa: 1.01CX LogP: 0.38CX LogD: 0.38
Aromatic Rings: 2Heavy Atoms: 18QED Weighted: 0.68Np Likeness Score: -0.04

References

1. Abushanab E, Sarma MS..  (1989)  1',2'-seco-dideoxynucleosides as potential anti-HIV agents.,  32  (1): [PMID:2909746] [10.1021/jm00121a016]

Source